October 19-22, 2020
Now Delivered 100% Virtually,
in Eastern Standard Time (EST)
The cell and gene therapy event for ground breaking bioprocessing, manufacturing & supply chain strategies
Revolutionize your cell, gene & gene edited ex vivo cell therapy programs as world renowned leaders share the latest analytical techniques & vector technologies at this global event
NEWS FLASH: BRAND NEW GLOBAL 2020 VIRTUAL EVENT!
In light of the current global climate, it is more important than ever for the cell & gene therapy community to connect with one another, strategize and share ideas – All in a safe, responsible way. With our dedication to address the most pressing issues, our cell and gene therapy events, now taking place October 19 - 22, have undergone a timely transformation, moving to an all-digital format and offering attendees the ability to participate in virtual content, exhibits and networking opportunities.
Cell Therapy
Cell Therapy
- Push the boundaries of process development with novel considerations & strategies
- Transition to a more standardizes approach to raw material selection & supply
- Improve confidence in your supply chain with next generation manufacturing and cryo techniques
Gene Edited Ex Vivo Cell Therapy
Gene Edited Ex Vivo Cell Therapy
- Build a strategy for next generation allogeneic CAR & T cell therapies
- Get to grips with different manufacturing infrastructures & commercialization strategies
- Understand effective testing, characterization & validation approaches
In Vivo Gene Therapy
In Vivo Gene Therapy
- Optimize next generation cell lines and address the current challenges with viral vectors
- Work towards continuous bioprocessing of vectors with enabling manufacturing tech
- Ensure high throughput applications in downstream processing
CRITICAL CELL & GENE THERAPY INSIGHTS FROM 70+ EXPERTS DURING A TIME OF TRANSFORMATIVE CHANGE, FEATURING:
Cell & Gene Therapy techniques and technologies – What you want. When you want it
Access all of the extensively researched agenda and sessions with the novelty of being able to view it at your own pace. How? All presentations will be made available both live and on-demand for 30 days, so you will be able to attend more presentations than ever before! Have 2 live sessions that you want to attend at the same time? Now you can watch one live and watch the other on-demand at a time that suits you.
Assessing the Future Prospects of Upstream Bioprocessing Systems for Commercial AAV Production
Scott Jeffers, Director, UniQure, USA
Raw Materials: BOMs, Risks & Securing Supply
Tom Walls, Associate Director Supply Chain, bluebird bio, USA
AI in Cell and Gene Therapy Manufacturing
Michael Roberts, Chief Technology Officer (Europe), Asklepios
BioPharmaceutical, Inc., UK
Product Dependent Cryopreservation Protocols
David McKenna, Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Minnesota, USA
Fresh vs. Cryopreserved: Tightening up Supply Chains
Jason Acker, Professor, Laboratory Medicine and Pathology, University of Alberta, Canada
Implementation of “off the shelf” Closed Systems fit for every purpose
Ali Mohamed, VP, CMC, Immatics, USA
Poster Presentation
Consider presenting a poster at this virtual event to derive more value from attending. Share your research with your peers and learn from other posters as well. Many attendees tell us that being selected for a poster presentation helps to facilitate their company approval process to attend the event. Submit your poster abstract online today using the form below.
Deadline: 2nd October 2020
CONNECT WITH KEY BUYERS AT Cell & Gene Therapy 2020 VIRTUALLY
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
(Companies A-L) Contact Kristin Skahan: Kristin.Skahan@informa.com | +1-857-504-6730
(Companies M-Z) Contact Perri Lucatello: Perri.Lucatello@informa.com | +44 (0)20 7017 7247
